InsidersTradesSigma
PHARMANUTRA PHARMANUTRA - PHN: IL CDA APPROVA IL PROGETTO DI BILANCIO DI ESERCIZIO E IL BILANCIO CONSOLIDATO AL 31 DICEMBRE 2025 Stock: price and management transactions · Italy · Consob
CONSOB:pharmanutra-pharmanutra-phn-il-cda-approva-il-progetto-di-bilancio-di-esercizio--613f82IT·ConsobHealth Care
Follow the PHARMANUTRA PHARMANUTRA - PHN: IL CDA APPROVA IL PROGETTO DI BILANCIO DI ESERCIZIO E IL BILANCIO CONSOLIDATO AL 31 DICEMBRE 2025 stock price and the full directors' dealings record of the company, a listed equity based in Italy. Shares are quoted on IT IT, under the authority of Consob. Operating in the Health Care sector, PHARMANUTRA PHARMANUTRA - PHN: IL CDA APPROVA IL PROGETTO DI BILANCIO DI ESERCIZIO E IL BILANCIO CONSOLIDATO AL 31 DICEMBRE 2025 has logged 0 reports. All data is accessible without an account.
0
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Declarations0 total
No declarations found
0 of 0 declarations